We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.62B
AUM Growth
+$99.5M
Cap. Flow
-$24.9M
Cap. Flow %
-1.54%
Top 10 Hldgs %
17.08%
Holding
826
New
61
Increased
333
Reduced
360
Closed
60
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGII icon
201
Digi International
DGII
$3.14B
$2.06M 0.13%
56,511
+4,153
+8% +$160K
IDV icon
202
iShares International Select Dividend ETF
IDV
$8.51B
$2.04M 0.13%
75,066
+12,145
+19% +$308K
RTX icon
203
RTX Corp
RTX
$302B
$2.01M 0.12%
19,940
+12,288
+161% +$1.16M
AKAM icon
204
Akamai
AKAM
$16.8B
$2.01M 0.12%
23,862
-2,826
-11% -$246K
HYD icon
205
VanEck High Yield Muni ETF
HYD
$4.4B
$2.01M 0.12%
39,775
+590
+2% +$29.8K
GOOG icon
206
Alphabet (Google) Class C
GOOG
$4.22T
$1.99M 0.12%
22,390
+5,152
+30% +$492K
EXC icon
207
Exelon
EXC
$46.2B
$1.98M 0.12%
45,861
+3,998
+10% +$158K
HYB
208
DELISTED
New America High Income Fund, Inc.
HYB
$1.98M 0.12%
300,257
-31,667
-10% -$213K
PNI
209
PIMCO New York Municipal Income Fund II
PNI
$77.9M
$1.98M 0.12%
249,039
+17,331
+7% +$134K
ARQT icon
210
Arcutis Biotherapeutics
ARQT
$3.32B
$1.97M 0.12%
132,772
+42,508
+47% +$743K
MCD icon
211
McDonald's
MCD
$193B
$1.96M 0.12%
7,427
+447
+6% +$118K
FAST icon
212
Fastenal
FAST
$60.2B
$1.95M 0.12%
82,552
-28,312
-26% -$692K
NI icon
213
NiSource
NI
$20.1B
$1.95M 0.12%
71,104
+9,971
+16% +$262K
CWB icon
214
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.58B
$1.95M 0.12%
30,286
-1,641
-5% -$107K
RCKT icon
215
Rocket Pharmaceuticals
RCKT
$377M
$1.94M 0.12%
98,991
+40,919
+70% +$754K
MO icon
216
Altria Group
MO
$108B
$1.88M 0.12%
41,116
+9,127
+29% +$413K
NCA icon
217
Nuveen California Municipal Value Fund
NCA
$304M
$1.86M 0.12%
220,516
+122,205
+124% +$1.03M
PM icon
218
Philip Morris
PM
$291B
$1.85M 0.11%
18,292
+3,131
+21% +$295K
HUM icon
219
Humana
HUM
$45B
$1.84M 0.11%
3,590
+411
+13% +$216K
TPVG icon
220
TriplePoint Venture Growth BDC
TPVG
$214M
$1.84M 0.11%
176,138
-23,445
-12% -$284K
TY icon
221
TRI-Continental Corp
TY
$1.9B
$1.82M 0.11%
71,151
+31,145
+78% +$833K
OKE icon
222
Oneok
OKE
$57.6B
$1.81M 0.11%
27,579
+1,703
+7% +$105K
MTB icon
223
M&T Bank
MTB
$36.6B
$1.78M 0.11%
12,307
+2,436
+25% +$401K
SJM icon
224
J.M. Smucker
SJM
$12.6B
$1.78M 0.11%
11,264
+1,739
+18% +$259K
HYEM icon
225
VanEck Emerging Markets High Yield Bond ETF
HYEM
$526M
$1.78M 0.11%
97,762
+3,603
+4% +$62.5K

Similar funds

Hennion & Walsh Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Hennion & Walsh Asset Management held 826 positions worth $1.62B, up 6.5% from $1.52B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hennion & Walsh Asset Management's Q4 2022 filing shows 61 new, 333 increased, 360 reduced and 60 closed positions. Its largest new stake was ConocoPhillips: 5,945 shares worth $702K. The largest sale was Global Blood Therapeutics, Inc., an estimated $8.48M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q4 2022 buy was ConocoPhillips: 5,945 shares worth $702K.
  • Hennion & Walsh Asset Management added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $7.48M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2022 reduction was Nuveen Municipal Credit Income Fund, cutting an estimated $7.27M.
  • Hennion & Walsh Asset Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $8.48M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.62B portfolio in Q4 2022.
  • Hennion & Walsh Asset Management opened 61 new positions and closed 60 in Q4 2022.
  • Hennion & Walsh Asset Management's portfolio value rose 6.5% quarter-over-quarter to $1.62B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.